San Diego, CA, United States of America

Robert Mckinlay

This inventor holds 1 USPTO granted patent. Top assignee: Biolinq Incorporated. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Mckinlay. Retrieved from https://idiyas.com/inventor/robert-mckinlay-61n11e7h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Robert Mckinlay and Microneedle-Based Analyte Monitoring

Introduction

Robert Mckinlay is an inventor based in San Diego, California. His patent work includes technology intended to improve sensor sensitivity in microneedle-based continuous analyte monitoring systems.

Latest Patents

Mckinlay is associated with one patent: METHOD FOR IMPROVED SENSOR SENSITIVITY OF A MICRONEEDLE-BASED CONTINUOUS ANALYTE MONITORING SYSTEM. The invention addresses sensor sensitivity in systems that use microneedles for continuous analyte monitoring. The supplied information does not specify the patent’s filing or grant date.

Career Highlights

Mckinlay works at Biolinq Incorporated, a company developing technology related to analyte monitoring. His listed patent reflects work on improving the sensing capabilities of microneedle-based monitoring systems.

Collaborations

Mckinlay’s listed coworkers include Alan Steven Campbell and Shuai Xu. The available information identifies these professional connections but does not specify their roles in the patent.

Conclusion

Robert Mckinlay’s patent work focuses on improving sensor sensitivity for microneedle-based continuous analyte monitoring, connecting his invention to Biolinq Incorporated’s work in this field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…